Skip to main content
NCBI home page
Clinical Molecular Pathology logoLink to Clinical Molecular Pathology
. 1995 Oct;48(5):M288–M290. doi: 10.1136/mp.48.5.m288

Identification of a thrombin receptor with factor Xa receptor and tissue factor in human pancreatic carcinoma cells

A K Kakkar 1,2,3,4, N R Lemoine 1,2,3,4, S R Stone 1,2,3,4, D Altieri 1,2,3,4, R C N Williamson 1,2,3,4
PMCID: PMC407987  PMID: 16696024

Abstract

Venous thromboembolism is a common feature of pancreatic cancer. The underlying mechanism is unclear, but is likely to involve thrombin generation on the cell surface. Human pancreatic carcinoma cell lines (n=8) have been studied immmunohistochemically for the expression of tissue factor, factor Xa receptor, and thrombin receptor. Each antigen had a distinct pattern of immunoreactivity in cell membrane and cytoplasm. Tissue factor was predominantly localised to the membrane, whereas thrombin and factor Xa receptor were largely cytoplasmic in distribution. The results support the hypothesis of a coagulation cascade that starts with tissue factor, leads to thrombin generation, and might confer a biological advantage on tumour cells.

Keywords: Thrombin receptor

Keywords: pancreatic cancer

Full text

PDF
M288

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altieri D. C. Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa. J Biol Chem. 1994 Feb 4;269(5):3139–3142. [PubMed] [Google Scholar]
  2. Coughlin S. R. Thrombin receptor structure and function. Thromb Haemost. 1993 Jul 1;70(1):184–187. [PubMed] [Google Scholar]
  3. Donati M. B. Cancer and thrombosis. Haemostasis. 1994 Mar-Apr;24(2):128–131. doi: 10.1159/000217092. [DOI] [PubMed] [Google Scholar]
  4. Dvorak H. F., Senger D. R., Dvorak A. M. Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metastasis Rev. 1983;2(1):41–73. doi: 10.1007/BF00046905. [DOI] [PubMed] [Google Scholar]
  5. Esumi N., Fan D., Fidler I. J. Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Cancer Res. 1991 Sep 1;51(17):4549–4556. [PubMed] [Google Scholar]
  6. Gasic G. P., Arenas C. P., Gasic T. B., Gasic G. J. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2317–2320. doi: 10.1073/pnas.89.6.2317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Glusa E. Vascular effects of thrombin. Semin Thromb Hemost. 1992;18(3):296–304. doi: 10.1055/s-2007-1002568. [DOI] [PubMed] [Google Scholar]
  8. Gordon S. G. Cancer cell procoagulants and their implications. Hematol Oncol Clin North Am. 1992 Dec;6(6):1359–1374. [PubMed] [Google Scholar]
  9. Howells G. L., Macey M., Curtis M. A., Stone S. R. Peripheral blood lymphocytes express the platelet-type thrombin receptor. Br J Haematol. 1993 May;84(1):156–160. doi: 10.1111/j.1365-2141.1993.tb03039.x. [DOI] [PubMed] [Google Scholar]
  10. Kakkar A. K., Lemoine N. R., Scully M. F., Tebbutt S., Williamson R. C. Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg. 1995 Aug;82(8):1101–1104. doi: 10.1002/bjs.1800820831. [DOI] [PubMed] [Google Scholar]
  11. Kanthou C., Parry G., Wijelath E., Kakkar V. V., Demoliou-Mason C. Thrombin-induced proliferation and expression of platelet-derived growth factor-A chain gene in human vascular smooth muscle cells. FEBS Lett. 1992 Dec 14;314(2):143–148. doi: 10.1016/0014-5793(92)80961-f. [DOI] [PubMed] [Google Scholar]
  12. Medrano E. E., Cafferata E. G., Larcher F. Role of thrombin in the proliferative response of T-47D mammary tumor cells. Mitogenic action and pleiotropic modifications induced together with epidermal growth factor and insulin. Exp Cell Res. 1987 Oct;172(2):354–364. doi: 10.1016/0014-4827(87)90393-4. [DOI] [PubMed] [Google Scholar]
  13. Nierodzik M. L., Plotkin A., Kajumo F., Karpatkin S. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Invest. 1991 Jan;87(1):229–236. doi: 10.1172/JCI114976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Yoshida E., Verrusio E. N., Mihara H., Oh D., Kwaan H. C. Enhancement of the expression of urokinase-type plasminogen activator from PC-3 human prostate cancer cells by thrombin. Cancer Res. 1994 Jun 15;54(12):3300–3304. [PubMed] [Google Scholar]

Articles from Clinical Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES